White label – Pompe disease - ClinicalTrials.eu

Study on the Effects of Morphine Sulfate for Relieving Breathlessness and Cough in Patients with Fibrotic Interstitial Lung Disease

Recruiting

3 1 1
Investigated Diseases:
- Interstitial lung disease
Investigated Drugs:
- Morphine Sulfate
- Placebo
Study on the Effects of Semaglutide, Dapagliflozin, and Metformin in Patients with Coronary Artery Disease and Prediabetes

Recruiting

3 1 1 1
Investigated Diseases:
Investigated Drugs:
Study Comparing Medroxyprogesterone Acetate and Ganirelix for Women Undergoing Fertility Treatment with Embryo Accumulation

Recruiting

3 1 1 1
Investigated Diseases:
- Infertility female
Investigated Drugs:
- Ganirelix
- Medroxyprogesterone Acetate
Study on the Effects of Levosimendan for Patients with Cardiogenic Shock Being Weaned from ECMO

Recruiting

2 1 1
Investigated Diseases:
- Cardiogenic shock
Investigated Drugs:
Study on Treatment-Free Intervals for Newly Diagnosed Multiple Myeloma Patients Using Daratumumab, Lenalidomide, and Dexamethasone

Recruiting

3 1 1 1
Investigated Drugs:
Study Comparing MK-2870 and Pembrolizumab Combination to Pembrolizumab Alone for Patients with Metastatic Non-Small Cell Lung Cancer with High PD-L1 Levels

Recruiting

3 1 1 1
Investigated Diseases:
- Non-small cell lung cancer metastatic
Investigated Drugs:
+3
Study Comparing Isotretinoin with Doxycycline, Tretinoin, and Adapalene for Moderate Acne in Patients with Skin of Color

Recruiting

3 1 1 1
Investigated Diseases:
- Acne
Investigated Drugs:
Study on RYZ101 for Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors After Previous Treatment

Recruiting

3 1 1 1
Investigated Diseases:
- Gastroenteropancreatic neuroendocrine tumour disease
Investigated Drugs:
Study on Pembrolizumab with Chemotherapy for Early-Stage Triple-Negative Breast Cancer in Patients with High TILs

Recruiting

2 1 1 1
Investigated Diseases:
- Triple negative breast cancer
Investigated Drugs:
Study of Cytarabine, Daunorubicin, and Clofarabine for Children with Relapsed or Refractory Acute Myeloid Leukemia (AML)

Recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia
Investigated Drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies